https://mundo.sputniknews.com/20210922/brasil-destaca-seleccion-de-oms-para-producir-vacunas-contra-covid-19-en-america-latina-1116301698.html
Brazil highlights WHO selection to produce COVID-19 vaccines in Latin America
Brazil highlights WHO selection to produce COVID-19 vaccines in Latin America
RÍO DE JANEIRO (Sputnik) – The World Health Organization (WHO) selected the Institute of Immunobiological Technology (Bio-Manguinhos) of the Foundation … 09.22.2021, Sputnik Mundo
2021-09-22T01:55+0000
2021-09-22T01:55+0000
2021-09-22T01:55+0000
Latin America
Brazil
/html/head/meta[@name=”og:title”]/@content
/html/head/meta[@name=”og:description”]/@content
–
https://cdnn1.mundo.sputniknews.com/img/07e5/01/1c/1094253880_0:73:3381:1974_1920x0_80_0_0_81aa2768da106fdc1a3f297e3941acad.jpg
The president of Fiocruz, Nísia Trindade Lima, highlighted the support of the WHO and said that it will be decisive so that the vaccine in which they work is developed quickly and within the global safety and quality protocols. The world body also selected the company Argentina Sinergium Biotech for this purpose. According to Fiocruz, the choice of Bio-Manguinhos occurred due to “promising advances in the technological development of an mRNA vaccine against COVID-19, currently in the preclinical phase.” The selection was announced by the chief scientist of the WHO, Soumya Swaminathan, and the deputy director of the Pan American Health Organization (PAHO), Jarbas Barbosa, during a event within the framework of the 59th meeting of the Directing Council of the regional organization. Through a statement, PAHO highlights that both companies “have extensive experience in the production and development of vaccines and other biotech medical products, “and notes that the two centers will help address the COVID-19 pandemic and” future infectious disease challenges. “The selection is the result of a call for proposals. that the WHO launched last April that attracted some thirty Latin American companies and scientific institutions. The PAHO statement recalls that the American continent has been the most affected by COVID-19, with 87.6 million registered cases and more than 2.16 million deaths. Regarding the distribution of vaccines, it stands out that it continues to be uneven and that few countries in the region have reached the vaccination goal of 40% of the population established by the WHO.
https://mundo.sputniknews.com/20210826/brasil-autoriza-las-pruebas-de-la-vacuna-estadounidense-inovio-contra-el-covid-19-1115421400.html
https://mundo.sputniknews.com/20210818/brasil-no-autoriza-vacunas-contra-el-covid-19-de-sinovac-en-menores-de-edad-1115207749.html
daniel danny
Herpes Treatment Experience Report I have been diagnosed with genital herpes for 2 years and am looking for a cure. I read a testimonial on this platform of a woman who was cured of diabetes with Dr. Ahmed Usman Herbal Medicine after much discussion and some questions, prepared medicinal herbs and asked for my direction. 3 days later, I received the herbal medicine and its prescription, including the doctor’s official email address. I contacted the doctor due to his disability and took medicinal herbs for 21 days. After finishing the herbal medicine, I went for a test and my IgG result was confirmed negative and no virus was found in my blood. Contact Dr. Ahmed and let yourself be cured. send an email to; [email protected] or send him a whatsapp text message +14436204203. Has herbal remedies for diabetes, hepatitis, cancer, leukemia, fibro
0
–
1
Brazil
Sputnik Mundo
+74956456601
MIA “Rosiya Segodnya”
2021
Sputnik Mundo
+74956456601
MIA “Rosiya Segodnya”
es_ES
Sputnik Mundo
+74956456601
MIA “Rosiya Segodnya”
–https://cdnn1.mundo.sputniknews.com/img/07e5/01/1c/1094253880_324:0:3055:2048_1920x0_80_0_0_7ea4ef141be62535a5da993e54d20b43.jpg
Sputnik Mundo
+74956456601
MIA “Rosiya Segodnya”
Sputnik Mundo
+74956456601
MIA “Rosiya Segodnya”
brazil, world health organization
–
RÍO DE JANEIRO (Sputnik) – The World Health Organization (WHO) selected the Institute of Immunobiological Technology (Bio-Manguinhos) of the Oswaldo Cruz Foundation (Fiocruz), linked to the Brazilian Ministry of Health, as a center for development and production of vaccines with messenger RNA technology in Latin America.
–
The president of Fiocruz, Nísia Trindade Lima, highlighted the support of the WHO and said that it will be decisive so that the vaccine in which they work is developed quickly and within the global protocols of safety and quality.
–
“With this project and the support of the WHO, we reaffirm our commitment to science and technology at the service of the population,” said Trindade Lima, who added that it is too early to talk about dates and calendars.
—
The world body also selected the Argentine company Sinergium Biotech for this purpose.
–
According to Fiocruz, the choice of Bio-Manguinhos came about due to “promising advances in the technological development of an mRNA vaccine against COVID-19, currently in the preclinical phase.”
–
The initiative had resources from the Ministry of Health and parliamentary amendments, says a statement from the state-run Brazil Agency.
–
Selection
The selection was announced by the chief scientist of the WHO, Soumya Swaminathan, and the deputy director of the Pan American Health Organization (PAHO), Jarbas Barbosa, during an event within the framework of the 59th meeting of the Directing Council of the regional organization.
–
Through a statement, PAHO highlights that both companies “have extensive experience in the production and development of vaccines and other biotechnological medical products,” and notes that the two centers will help to cope with the COVID-19 pandemic and “To Future Infectious Disease Challenges”.
–
“There is still a hard work ahead, but we are moved by the conviction that this effort will translate into timely and equitable access to vaccines in our region, which continues to be the most affected by this pandemic,” Barbosa said at the event after congratulating to the two selected companies.
—
The selection is the result of a call that the WHO launched last April that attracted some thirty Latin American companies and scientific institutions.
–
The PAHO statement recalls that the American continent has been the most affected by COVID-19, with 87.6 million registered cases and more than 2.16 million deaths.
–
Regarding the distribution of vaccines, it stands out that it continues to be uneven and that few countries in the region have reached the vaccination goal of 40% of the population established by the WHO.
— .
